Stoke Therapeutics, Inc. (STOK) NASDAQ

21.99

+1.31(+6.33%)

Updated at September 08 04:00PM

Currency In USD

Valuation

Market Cap595.72M
Enterprise Value470.06M
P/E Ratio24.45
PEG Ratio3.42
Price/Sales Ratio6.03
Price/Book Ratio3.83
Enterprise/Revenue5.52
Enterprise/EBITDA26.38

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.26
Operating Margin0.2

Management Effectiveness

Return On Assets0.14
Return On Equity0.18

Income Statement

Revenue36.56M
Revenue/Share3.43
Gross Profit36.56M
EBITDA-99.2M
Net Income-88.98M
Diluted EPS-1.65

Balance Sheet

Total Cash247.71M
Total Cash/Share4.24
Total Debt2.3M
Total Debt/Equity0
Current Ratio6.98
Book Value Per Share6.4

Price History

52-Week Change43.26
52-Week High22.39
52-Week Low5.35
Moving Average 50 Days14.76
Moving Average 200 Days11.1

Statistics

Average Volume773,651
Shares Outstanding54.8M
% Held by Institutions103.53

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A